A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major

Annals of Saudi Medicine

Volumn 28, Issue 5, 2008, Pages 361-366

  Najafipour, Farzad ^a,c   Aliasgarzadeh, Akbar ^a   Aghamohamadzadeh, Naser ^a   Bahrami, Amir ^a   Mobasri, Majid ^a   Niafar, Mitra ^a   Khoshbaten, Manouchehr ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Emam Reza Educational Hospital   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DEFEROXAMINE; ESTRADIOL; FOLLITROPIN; GLUCOSE; LUTEINIZING HORMONE; PHOSPHORUS; TESTOSTERONE; THYROTROPIN; THYROXINE; CHELATING AGENT;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CALCIUM BLOOD LEVEL; DIABETES MELLITUS; ENDOCRINE DISEASE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOGONADISM; HYPOTHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; IRON OVERLOAD; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PUBERTY DISORDERS; SCHOOL CHILD; SHORT STATURE; TESTOSTERONE BLOOD LEVEL; THALASSEMIA MAJOR; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; CHILD; CROSS-SECTIONAL STUDY; GLUCOSE TOLERANCE TEST; GONADAL DISEASE; GROWTH DISORDER;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHELATING AGENTS; CHILD; CROSS-SECTIONAL STUDIES; DEFEROXAMINE; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; GONADAL DISORDERS; GROWTH DISORDERS; HUMANS; HYPOCALCEMIA; HYPOTHYROIDISM; IRON OVERLOAD; MALE; YOUNG ADULT;

EID: 58249084521     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2008.361     Document Type: Article

References (34)

1. Bens EI, Schwartz E. Thalassemia syndromes in blood disease of infancy and childhood. Mosby: Philadelphia Press; 1990:428-440.
2. Lukens JN. The thalassemia and related disorders. In: Jonathan W, Pine Jr, editor. Wintrobe's clinical hematology. 10th ed. USA: Williams and Wilkins; 1999:1405-49.
3. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004 Oct;89(10):1187-93.
4. Raiola G, Galati MC, De Sanctis V, Caruso Nicoletti M, Pintor C, De Simone M, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003;16 Suppl 2:259-66.
5. Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY, Lin DT, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion dependent beta-thalassemia. J Pediatr Hematol Oncol. 2003;25(11):880-4.
6. Fung EB, Harmatz PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135:574.
7. Multicenter study on prevalence of endocrine complications in thalassemia major. Italian working Group on Endocrine Complications in Non-endocrine Disease. Clin Endocrinal. 1995;42(6):581-60.
8. Filosa A, Di Maio S, Aloj G, Acampora C. Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab. 2006 Dec;19(12):1397-404.
9. De Sanctis V, Eleftheriou A, Malaventura C. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:249-55.
10. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006 Apr;19(4):471-80.
11. Moayeri H, Oloomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Arch Iran Med. 2006 Oct;9(4):329-34.
12. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003 Aug 12;3(1):4.
13. Soliman AT, El Zalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999;45(1):23-30.
14. Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, et al. Growth and management of short stature in thalassaemia major. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:835-44.
15. Mostavafi H, Afkhamizadeh M, Rezvanfar M. Endocrine dysfunction in thalassemia major. Iranian J Endocrinol Metab. 2005;7(2):143-147.
16. Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997 Mar-Apr;10(2):175-84.
17. El-Hazmi MA, AL-Swailem A, AL-Fawaz I, Warsey A. Diabetes mellitus in children suffering from beta-thalassemia. J Trop Pediatr. 1994;40: 261-267.
18. Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006;134:438.
19. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian beta thalassemic patients: possible association with genotyping. Pediatr Diabetes. 2004;5(3):126-32.
20. Ramachandran A, Snehalatha C, Kapur A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094-1101.
21. Karahanyan E, Stoyanovo A, Moumdzhiev I, Ivanov I. Secondary diabetes in children with thalassemia major. Folia Med (Plovdiv). 1994;36(1): 29-34.
22. Chern JP, Lin KH, Lu KH, LU MY, Lin DT, Lin KS, et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care. 2001;24(5):850-4.
23. Monge L, Pinach S, Caramelino L, Bertero MT, Dallomo A, Carta Q. the possible role of autoimmunity in the pathogenesis of diabetes in betathalassemia major. Diabetes Metab. 2001;27(2 part 1):149-154.
24. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;Mar 162(3):139-46.
25. De Sanctis V, Vullo C, Bagni B, Chiccoli L. Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematol. 1992;88(2-3):105-8.
26. Garofalo F, Piga A, Lala R, Chiabotto S, Di Stefano M, Isaia GC. Bone metabolism in thalassemia. Ann N Y Acad Sci. 1998 June 30;850:475-8.
27. Gulati R, Bhatia v, Agrwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinal Metab. 2000;13(6):651-660.
28. Pantelakis S. Thyroid disorders and diabetes mellitus as complications of thalassaemia major. Acta Paediatr Suppl. 1994 Dec;406:111-3.
29. Landau H, Matoth I, Landau-Cordova Z, Goldfarb A, Rachmilewitz EA, Glaser B. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf). 1993 Jan;38(1):55-61.
30. Agarwal MB, Shah S, Vishwanathan C, Rajadhyaksha G, Bhave AA, Dube SR, et al. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr. 1992 Aug;29(8):997-102.
31. Margo S, Puzzanio P, Consario C. Hypothyroidism in patients with thalassemia syndromes. Acta Hematol. 1990;84:72-6.
32. Depaz G, Deville A, Coussement N. Thyroid function in thalassemia major. Ann Pediatr. 1985;32:809-11.
33. Phenekos C, Karamerou A, Pipis P. Thyroid function in patients with homozygous beta-thalassemia. Clin Endocrinol. 1984;20:445-50.
34. Senanayake MP, Suraweera SA, Hubert HD. Thyroid function in thalassaemia major. Ceylon Med J. 1999 Dec;44(4):166-8.